Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
12/2009
12/09/2009CN101596197A Quick-release medicinal composition and preparation method thereof
12/09/2009CN101596196A Ligustrazine and danshensu composition and pharmacology activity research
12/09/2009CN101596190A Pharmaceutical application of D-cycloserine
12/09/2009CN101596184A Application of rosmarinic acid as peroxynitrite inhibitor
12/09/2009CN101596160A Alpha-asarone mixed micelle injectio and preparation method thereof
12/09/2009CN101596011A Plants drink capable of relieving or neutralizing the effect of alcohol and preparation method thereof
12/09/2009CN100567483C FAD4, FAD5, FAD5-2 and FAD6 fatty acid desaturase enzyme family members and uses thereof
12/09/2009CN100567322C Polypeptide for inhibiting growth differentiation factor activity and cell expressing the same
12/09/2009CN100567293C N-substituted nonaryl-heterocyclic NMDA/NR2B antagonists
12/09/2009CN100567288C 4-tetrazolyl-4-phenylpiperidine derivatives for treating pain
12/09/2009CN100567266C Cannabinoid receptor ligands
12/09/2009CN100567253C Novel succinate salt of O-demethyl-venlafaxine
12/09/2009CN100566744C Externally applied for treating hemicrania
12/09/2009CN100566736C Massage agent for treating malaise of head and method for preparing the same
12/09/2009CN100566714C Compositions of huperzia serrata alkaloids comprising huperzine A and huperzine B and preparation thereof
12/08/2009US7629475 kappa opioid receptors agonist; antidepressants for treating mood disorders, such as depressive disorders and manic disorders, psychological disorders
12/08/2009US7629468 Neuroprotectants, analgesics or anticonvulsants
12/08/2009US7629377 e.g. 1-Benzyl-3-pentyl-2-[6-(1H-tetraazol-5-ylmethoxy)-2-naphthyl]-1H-indole; stroke associated with or resulting from atrial fibrillation; thrombolytic agents for prohylaxis of cardiovascular disorders
12/08/2009US7629375 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods
12/08/2009US7629374 Use of aminoindazole derivatives for the inhibition of tau phosphorylation
12/08/2009US7629363 Diaryl substituted pyridinones
12/08/2009US7629362 2-pyridine carboxamide derivatives
12/08/2009US7629354 Use of phanquinone for the treatment of Alzheimer's disease
12/08/2009US7629350 CSBP/p38 kinase inhibitor; antiinflammatory agent; inflammatory bowel disease; tuberculosis, atherosclerosis, muscle degeneration, cachexia, psoriatic arthritis, rheumatoid arthritis; 8-(2,4,6-trifluorophenyl)-4-(2,4-difluorophenyl)-2-(2-hydroxy-1-hydroxymethylethylamino)-8H-pyridio[2,3]pyrimidin-7-one
12/08/2009US7629349 Parkinson's disease; antidepressants; cognition activators; analgesics; brain disorders; drug combination
12/08/2009US7629338 for treating migraine, headaches; N-[(4S)-3-Methyl-2,5-dioxo-1',3'-dihydrospiro[imidazolidine-4,2'-inden]-5'-yl]-2-((6+-)-2-oxo-6-phenylpiperidin-1-yl)acetamide
12/08/2009US7629318 Immunosuppressant compounds, methods and uses related thereto
12/08/2009US7628988 Induce cell differentiation; process control
12/08/2009US7628981 Strain of lactic acid bacterium and edible compositions, drugs and veterinary products containing it
12/08/2009CA2522180C 2-azabicyclo[3.3.1]nonane derivatives as opioid receptor antagonists
12/08/2009CA2482311C Furyl compounds
12/08/2009CA2440744C Il-12 expression controlling agent
12/08/2009CA2422354C Pyrazole compounds useful as protein kinase inhibitors
12/08/2009CA2422342C Novel amide derivatives and medicinal use thereof
12/08/2009CA2419301C Quinazoline derivatives
12/08/2009CA2404725C Extrusion die
12/08/2009CA2399802C Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof
12/08/2009CA2398794C 1,3-disubstituted pyrrolidines as alpha-2-adrenoceptor antagonists
12/08/2009CA2374898C Pyrazinyl-piperazine compounds, their use and preparation
12/08/2009CA2369979C 4,5-diaryl-3(2h)-furanone derivatives as cyclooxygenase-2 inhibitors
12/08/2009CA2361525C Diazabicyclic derivatives as nicotinic acetylcholine receptor ligands
12/08/2009CA2359242C Growth differentiation factor inhibitors and uses therefor
12/08/2009CA2314613C Azolo triazines and pyrimidines
12/08/2009CA2302275C Solid solution beadlet
12/08/2009CA2263898C Composition and method for repairing neurological tissue
12/03/2009WO2009146365A1 Hydroxy substituted thieno pyrimidinones as melanin concentrating hormone receptor-1 antagonists
12/03/2009WO2009146288A1 Processes and compounds for the preparation of normorphinans
12/03/2009WO2009146218A2 Compounds including an anti-inflammatory pharmacore and methods of use
12/03/2009WO2009146216A2 Antioxidant inflammation modulators: novel derivatives of oleanolic acid
12/03/2009WO2009146031A1 Methods of treating disease-induced ataxia and non-ataxic imbalance
12/03/2009WO2009145996A2 Amide derivatives as positive allosteric modulators and methods of use thereof
12/03/2009WO2009145816A2 Novel n-benzylamide substituted derivatives of 2-(acylamido)acetic acid and 2-(acylamido)propionic acids: potent neurological agents
12/03/2009WO2009145721A1 Isoindoline derivatives comprising phenyl groups and their use in the treatment of pain disorders
12/03/2009WO2009145720A1 Isoindoline derivatives comprising additional heterocyclic groups and their use in the treatment of pain disorders
12/03/2009WO2009145719A1 Isoindoline derivatives comprising a cyano group and their use in the treatment of pain disorders
12/03/2009WO2009145718A1 Isoindoline derivatives comprising an additional heterocyclic group and their use in the treatment of pain disorders
12/03/2009WO2009145363A1 Composition comprising a hot water extract of hemerocallis plants, said composition being effective in treating fatigue by having antidepressant properties or by improving sleep
12/03/2009WO2009145357A1 In 1-position durch einen ring substituierte benzo [1, 4] diazepine zur verwendungs als antidepressiva
12/03/2009WO2009145289A1 Inhibitor of analgesic tolerance
12/03/2009WO2009145269A1 Transdermal preparation
12/03/2009WO2009145238A1 Immunomodulatory agent and use thereof
12/03/2009WO2009145219A1 Therapeutic agent for alzheimer's disease
12/03/2009WO2009145177A1 Donepezil-containing patch preparation and packaging thereof
12/03/2009WO2009145171A1 Novel benzothiophene oxide derivative and salt thereof
12/03/2009WO2009145067A1 Therapeutic agent for pain and use thereof
12/03/2009WO2009144961A1 Substituted carbinol compound having cyclic linker
12/03/2009WO2009144718A1 Mesenchymal stem cells for the treatment of cns diseases
12/03/2009WO2009144632A1 Novel compounds
12/03/2009WO2009144494A1 Phenoxypyridinylamide derivatives and their use in the treatment of pde4 mediated disease states
12/03/2009WO2009144483A1 Use of zolpidem for cognitive enhancement
12/03/2009WO2009144395A1 Polysubstituted derivatives of 2-heteroaryl-6-phenyl-imidazo[l,2- α] pyridines, and preparation and therapeutic use thereof
12/03/2009WO2009144394A1 Polysubstituted 2-aryl-6-phenyl-imidazo[l,2- α] pyridine derivatives, and preparation and therapeutic use thereof
12/03/2009WO2009144392A1 Polysubstituted derivatives of 6-heteroaryl-imidazo[l,2- α] pyridines, and preparation and therapeutic use thereof
12/03/2009WO2009144391A1 Polysubstituted derivatives of 2-aryl-6-phenyl-imidazo[l,2- α] pyridines, and preparation and therapeutic use thereof
12/03/2009WO2009144037A1 Use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of various diseases
12/03/2009WO2009143865A1 Use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of various diseases
12/03/2009WO2009143556A1 TREATMENTS FOR EXCITOTOXICITY AND Aß-MEDIATED TOXICITY AND AGE-ASSOCIATED NEURONAL DYSFUNCTION
12/03/2009WO2009126778A3 Compositions and methods for treating neurodegenerative diseases
12/03/2009WO2009120717A3 Pyrido [3, 4-b] indoles and methods of use
12/03/2009WO2009118657A3 Polymorphic form of an aminoindan mesylate derivative
12/03/2009WO2009118655A3 Highly pure paliperidone or a pharmaceutically acceptable salt thereof substantially free of keto impurity
12/03/2009WO2009108657A3 Heteroaryl derivatives as cftr modulators
12/03/2009WO2009101185A3 A polymorphic form of a pyrazino [2, 3-h] [3] benzazepine derivative
12/03/2009WO2009071519A9 Oxadiazole derivatives and their use as nicotinic acetylcholine receptor modulators
12/03/2009WO2009043479A3 Use of eaa-mart1 (26-35) for the treatment of human cytomegalovirus infections
12/03/2009WO2009043478A3 Use of bubuc and optionally eaa-mart1 (26-35) as a therapeutic agent for the treatment of hcmv infections
12/03/2009WO2009035473A3 Method of treating binge eating disorder, obesity resulting from binge eating behavior and depressive disorders
12/03/2009WO2008155534A9 Neurosteroid compounds
12/03/2009WO2008139235A8 Novel piperazine salts as d3/d2 antagonists
12/03/2009WO2007138334A3 Methods for identifying an agent that modulates type i or type ii pip kinase activity or expression
12/03/2009US20090298947 Polymorphic and amorphous forms of lacosamide and amorphous compositions
12/03/2009US20090298929 Novel natural cyclodextrin complexes
12/03/2009US20090298892 Treatment Methods Employing Histamine H3 Receptor Antagonists, Including Betahistine
12/03/2009US20090298886 2-indolinone derivatives as multi-target protein kinase inhibitors and histone deacetylase inhibitors
12/03/2009US20090298883 N-piperidinyl acetamide derivatives as calcium channel blockers
12/03/2009US20090298882 Thioxoisoindoline compounds and compositions comprising and methods of using the same
12/03/2009US20090298879 Impurities of Donepezil
12/03/2009US20090298876 Modulators of atp-binding cassette transporters
12/03/2009US20090298864 Methods for Treating Mild Cognitive Impairment
12/03/2009US20090298852 Pellet-form slow-release preparation for vertigo
1 ... 519 520 521 522 523 524 525 526 527 528 529 530 531 532 533 534 535 536 537 538 539 ... 1833